Cargando…

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma

BACKGROUND: Bone morphogenetic proteins (BMPs) regulate tumor progression via binding to their receptors (BMPRs). However, the expression and clinical significance of BMPs/BMPRs in lung adenocarcinoma remain unclear due to a lack of systematic studies. METHODS: This study screened differentially exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Wangyang, Xiao, Han, Zhao, Rong, Li, Dong, Li, Kuo, Meng, Yunchong, Chen, Jiaping, Wang, Yangwei, Liao, Yongde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569625/ https://www.ncbi.nlm.nih.gov/pubmed/34745928 http://dx.doi.org/10.3389/fonc.2021.608239

Ejemplares similares

Upregulation of estrogen receptor beta protein but not mRNA predicts poor prognosis and may be associated with enhanced translation in non-small cell lung cancer: a systematic review and meta-analysis
por: Meng, Wangyang, et al.
Publicado: (2021)

A five-gene expression signature of centromeric proteins with prognostic value in lung adenocarcinoma
por: Wang, Yangwei, et al.
Publicado: (2023)

Stearoyl-CoA Desaturases1 Accelerates Non-Small Cell Lung Cancer Metastasis by Promoting Aromatase Expression to Improve Estrogen Synthesis
por: Chen, Jiaping, et al.
Publicado: (2023)

Critical Roles of METTL3 in Translation Regulation of Cancer
por: Meng, Wangyang, et al.
Publicado: (2023)

Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma
por: Xu, Zhixiao, et al.
Publicado: (2021)

Immune characteristics analysis and construction of a four-gene prognostic signature for lung adenocarcinoma based on estrogen reactivity
por: Wang, Yangwei, et al.
Publicado: (2023)

Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
por: Peng, Lu-Shan, et al.
Publicado: (2022)

Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer
por: Xiao, Han, et al.
Publicado: (2023)

Prognostic Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma
por: Lian, Zengzhi, et al.
Publicado: (2022)

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
por: Chai, Xupeng, et al.
Publicado: (2021)

Deciphering Prognostic Value of TTN and Its Correlation With Immune Infiltration in Lung Adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2022)

Minimally invasive esophagectomy with intrathoracic anastomosis in a situs inversus totalis patient
por: Meng, Yunchong, et al.
Publicado: (2020)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
por: Li, Jingyang, et al.
Publicado: (2022)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021)

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022)

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
por: Liu, Jun, et al.
Publicado: (2023)

Receptor–ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma
por: Mao, Shengqiang, et al.
Publicado: (2023)

GBE1 Is an Independent Prognostic Marker and Associated With CD163(+) Tumor-Associated Macrophage Infiltration in Lung Adenocarcinoma
por: Liang, Yicheng, et al.
Publicado: (2022)

Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma
por: Mu, Teng, et al.
Publicado: (2022)

Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer
por: Liu, Ming, et al.
Publicado: (2023)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma
por: Cai, Lei, et al.
Publicado: (2021)

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma
por: Yuan, Ligong, et al.
Publicado: (2021)

Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis
por: Pan, Ya-Qiang, et al.
Publicado: (2022)

The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm
por: Zhang, Hua, et al.
Publicado: (2021)

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers
por: Meng, Chunliu, et al.
Publicado: (2022)

A prognostic signature model for unveiling tumor progression in lung adenocarcinoma
por: Li, Zijian, et al.
Publicado: (2022)

The prognostic value and immunological role of angiogenesis-related patterns in colon adenocarcinoma
por: Sun, Weijie, et al.
Publicado: (2022)

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma
por: Pal, Krishnendu, et al.
Publicado: (2022)

Diagnostic, Therapeutic Predictive, and Prognostic Value of Neutrophil Extracellular Traps in Patients With Gastric Adenocarcinoma
por: Zhang, Yiyin, et al.
Publicado: (2020)

Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
por: Peng, Jianfeng, et al.
Publicado: (2021)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021)

Prognostic Value of Pre-Treatment CT Radiomics and Clinical Factors for the Overall Survival of Advanced (IIIB–IV) Lung Adenocarcinoma Patients
por: Hong, Duo, et al.
Publicado: (2021)

Diagnostic value of dual-layer spectral detector CT in differentiating lung adenocarcinoma from squamous cell carcinoma
por: Mu, Ronghua, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma
por: Li, Xuedong, et al.
Publicado: (2023)

Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors’ Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma
por: Zhang, Lijuan, et al.
Publicado: (2021)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma
por: Li, Xinge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upv3qkqg0oef3ri0gj7j1pctkq